As a result, both CD4+ and CD8+ T cell counts were drastically reduced upon RMD administration (Fig 6b and 6c, respectively), but similar to the overall lymphopenia, they rebounded to pretreatment levels within one week (Fig 6b and 6c). This evidence concerns the gene CD4 and lymphopenia.